495 related articles for article (PubMed ID: 16237706)
21. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
22. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs.
Ding XR; Yang J; Sun DC; Lou SK; Wang SQ
Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500
[TBL] [Abstract][Full Text] [Related]
23. Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro.
Wang GF; Shi LP; Ren YD; Liu QF; Liu HF; Zhang RJ; Li Z; Zhu FH; He PL; Tang W; Tao PZ; Li C; Zhao WM; Zuo JP
Antiviral Res; 2009 Aug; 83(2):186-90. PubMed ID: 19463857
[TBL] [Abstract][Full Text] [Related]
24. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
25. [Replication and transfection of hepatitis B virus DNA into primary duck hepatocytes].
Yao Y; Huang A; Tang N; Wang B; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2002 Feb; 10(1):34-6. PubMed ID: 11856500
[TBL] [Abstract][Full Text] [Related]
26. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.
Wang WN; Yang XB; Liu HZ; Huang ZM; Wu GX
Acta Pharmacol Sin; 2005 May; 26(5):587-92. PubMed ID: 15842778
[TBL] [Abstract][Full Text] [Related]
27. Isolation and identification of an anti-hepatitis B virus compound from Hydrocotyle sibthorpioides Lam.
Huang Q; Zhang S; Huang R; Wei L; Chen Y; Lv S; Liang C; Tan S; Liang S; Zhuo L; Lin X
J Ethnopharmacol; 2013 Nov; 150(2):568-75. PubMed ID: 24051027
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of viral replication by genetically engineered mutants of the duck hepatitis B virus core protein.
von Weizsäcker F; Wieland S; Blum HE
Hepatology; 1996 Aug; 24(2):294-9. PubMed ID: 8690395
[TBL] [Abstract][Full Text] [Related]
30. Suppression of hepatitis B virus replication by microRNA-199a-3p and microRNA-210.
Zhang GL; Li YX; Zheng SQ; Liu M; Li X; Tang H
Antiviral Res; 2010 Nov; 88(2):169-75. PubMed ID: 20728471
[TBL] [Abstract][Full Text] [Related]
31. Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells.
Jia YY; Guan RF; Wu YH; Yu XP; Lin WY; Zhang YY; Liu T; Zhao J; Shi SY; Zhao Y
Mol Med Rep; 2014 Apr; 9(4):1381-7. PubMed ID: 24481875
[TBL] [Abstract][Full Text] [Related]
32. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the antiviral effects of 2' carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus.
Mason WS; Cullen J; Saputelli J; Wu TT; Liu C; London WT; Lustbader E; Schaffer P; O'Connell AP; Fourel I
Hepatology; 1994 Feb; 19(2):398-411. PubMed ID: 8294097
[TBL] [Abstract][Full Text] [Related]
34. Alternative methods for validation of cell culture infection with duck hepatitis B virus.
Sauerbrei A; Schacke M; Schultz U; Egerer R; Merkle I; Glebe D; Gerlich W; Wutzler P
J Virol Methods; 2005 Nov; 129(2):178-85. PubMed ID: 16002155
[TBL] [Abstract][Full Text] [Related]
35. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
36. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors.
Ren S; Nassal M
J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483
[TBL] [Abstract][Full Text] [Related]
38. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes.
Kan Q; Li D; Yu Z
J Virol Methods; 2012 Mar; 180(1-2):84-90. PubMed ID: 22240074
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment.
Xie HY; Xia WL; Zhang CC; Wu LM; Ji HF; Cheng Y; Zheng SS
Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333
[TBL] [Abstract][Full Text] [Related]
40. Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line.
Chang JS; Liu HW; Wang KC; Chen MC; Chiang LC; Hua YC; Lin CC
Antiviral Res; 2005 Apr; 66(1):29-34. PubMed ID: 15781129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
